This kit uses RT-PCR to detect epidermal growth factor receptor (EGFR) gene mtuation in plasma or formalin-fixed paraffin-embedded tissue (FFPE). Test results may serve as a reference for clinical evaluation of defined EGFR gene mutations in non-small-cell lung cancer (NSCLC) patients. Confirmed mutation: recommended medications include gefitinib, afatinib, dacomitinib, erlotinib, osimertinib, etc.
The test uses specific gene sequences as target regions. Human genomic sequence is used as internal quality control.
